2 studies found for:    CDK19
Show Display Options
Rank Status Study
1 Completed A Study Of Selective Cyclin Dependent Kinase Inhibitor P1446A-05 In Subjects With Advanced Refractory Malignancies
Conditions: Solid Tumor;   Hematologic Malignancy
Intervention: Drug: P1446A-05
2 Recruiting Activity and Tolerability of Pazopanib in Advanced and/or Metastatic Liposarcoma. A Phase II Clinical Trial
Condition: Advanced and / or Metastatic Liposarcoma
Intervention: Drug: Pazopanib

Indicates status has not been verified in more than two years